BNTC
BNTC
NASDAQ · Biotechnology

Benitec Biopharma Inc

$13.04
+0.16 (+1.24%)
As of Jun 24, 3:01 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +106.1% upside
Low Target $21.20
Average Target $26.87
High Target $38.04
Current Price $13.04
Current
$13.04
Target
$26.87
$21.20 $26.87 avg $38.04
Scenario Analysis
Bear Case
$21.20
62.6%
Low target
Base Case
$26.87
+106.1%
Avg target
Bull Case
$38.04
+191.7%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$16.76
-22.2% from high
52-Week Low
$9.85
+32.4% from low
Target vs 52W High
$26.87
+60.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%